|Other names||Flumethasone (USAN)|
|AHFS/Drugs.com||Micromedex Detailed Consumer Information|
|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||410.458 g·mol−1|
|3D model (JSmol)|
|(what is this?)|
It was patented in 1951 and approved for medical use in 1964.
Flumethasone is 420 times as potent as cortisone in an animal model for anti-inflammatory activity.
Trade names include Locacorten, Locorten, and Orsalin. It is available in combination with clioquinol, under the trade name Locacorten-Vioform (in some countries Locorten-Vioform), for the treatment of otitis externa and otomycosis. It is usually formulated as the pivalic acid ester prodrug called flumetasone pivalate.